Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005681 | spliceosomal complex | 3 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
GO:0140513 | nuclear protein-containing complex | 2 | 2 |
GO:1990904 | ribonucleoprotein complex | 2 | 2 |
GO:0005634 | nucleus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9B3W6
Term | Name | Level | Count |
---|---|---|---|
GO:0000375 | RNA splicing, via transesterification reactions | 8 | 2 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 9 | 2 |
GO:0000398 | mRNA splicing, via spliceosome | 8 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006396 | RNA processing | 6 | 2 |
GO:0006397 | mRNA processing | 7 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0008380 | RNA splicing | 7 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0016071 | mRNA metabolic process | 6 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 115 | 117 | PF00675 | 0.347 |
CLV_NRD_NRD_1 | 188 | 190 | PF00675 | 0.433 |
CLV_NRD_NRD_1 | 19 | 21 | PF00675 | 0.536 |
CLV_PCSK_FUR_1 | 113 | 117 | PF00082 | 0.335 |
CLV_PCSK_KEX2_1 | 115 | 117 | PF00082 | 0.376 |
CLV_PCSK_KEX2_1 | 17 | 19 | PF00082 | 0.534 |
CLV_PCSK_KEX2_1 | 186 | 188 | PF00082 | 0.631 |
CLV_PCSK_PC1ET2_1 | 17 | 19 | PF00082 | 0.534 |
CLV_PCSK_PC1ET2_1 | 186 | 188 | PF00082 | 0.571 |
CLV_PCSK_SKI1_1 | 105 | 109 | PF00082 | 0.416 |
CLV_PCSK_SKI1_1 | 209 | 213 | PF00082 | 0.561 |
DEG_SPOP_SBC_1 | 142 | 146 | PF00917 | 0.414 |
DEG_SPOP_SBC_1 | 80 | 84 | PF00917 | 0.335 |
DOC_PP4_FxxP_1 | 169 | 172 | PF00568 | 0.171 |
DOC_USP7_MATH_1 | 132 | 136 | PF00917 | 0.301 |
DOC_USP7_MATH_1 | 148 | 152 | PF00917 | 0.348 |
DOC_USP7_MATH_1 | 66 | 70 | PF00917 | 0.343 |
DOC_USP7_MATH_1 | 80 | 84 | PF00917 | 0.338 |
DOC_USP7_UBL2_3 | 186 | 190 | PF12436 | 0.574 |
DOC_USP7_UBL2_3 | 209 | 213 | PF12436 | 0.397 |
DOC_USP7_UBL2_3 | 72 | 76 | PF12436 | 0.335 |
DOC_WW_Pin1_4 | 144 | 149 | PF00397 | 0.480 |
LIG_14-3-3_CanoR_1 | 58 | 62 | PF00244 | 0.177 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.616 |
LIG_BRCT_BRCA1_1 | 200 | 204 | PF00533 | 0.508 |
LIG_eIF4E_1 | 163 | 169 | PF01652 | 0.289 |
LIG_FHA_2 | 180 | 186 | PF00498 | 0.566 |
LIG_LIR_Apic_2 | 166 | 172 | PF02991 | 0.171 |
LIG_LIR_Nem_3 | 201 | 207 | PF02991 | 0.440 |
LIG_Pex14_2 | 207 | 211 | PF04695 | 0.517 |
LIG_REV1ctd_RIR_1 | 209 | 213 | PF16727 | 0.530 |
LIG_SH2_STAP1 | 163 | 167 | PF00017 | 0.404 |
LIG_SH3_3 | 60 | 66 | PF00018 | 0.171 |
MOD_CK1_1 | 127 | 133 | PF00069 | 0.317 |
MOD_CK1_1 | 146 | 152 | PF00069 | 0.301 |
MOD_CK1_1 | 178 | 184 | PF00069 | 0.506 |
MOD_CK1_1 | 68 | 74 | PF00069 | 0.216 |
MOD_CK1_1 | 82 | 88 | PF00069 | 0.370 |
MOD_CK2_1 | 179 | 185 | PF00069 | 0.593 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.674 |
MOD_GlcNHglycan | 127 | 130 | PF01048 | 0.272 |
MOD_GlcNHglycan | 134 | 137 | PF01048 | 0.297 |
MOD_GlcNHglycan | 148 | 151 | PF01048 | 0.348 |
MOD_GlcNHglycan | 62 | 66 | PF01048 | 0.404 |
MOD_GlcNHglycan | 68 | 71 | PF01048 | 0.403 |
MOD_GlcNHglycan | 73 | 76 | PF01048 | 0.336 |
MOD_GSK3_1 | 120 | 127 | PF00069 | 0.268 |
MOD_GSK3_1 | 128 | 135 | PF00069 | 0.301 |
MOD_GSK3_1 | 142 | 149 | PF00069 | 0.243 |
MOD_GSK3_1 | 175 | 182 | PF00069 | 0.645 |
MOD_GSK3_1 | 20 | 27 | PF00069 | 0.628 |
MOD_GSK3_1 | 53 | 60 | PF00069 | 0.406 |
MOD_GSK3_1 | 61 | 68 | PF00069 | 0.344 |
MOD_GSK3_1 | 79 | 86 | PF00069 | 0.258 |
MOD_N-GLC_1 | 195 | 200 | PF02516 | 0.489 |
MOD_PIKK_1 | 195 | 201 | PF00454 | 0.516 |
MOD_PIKK_1 | 20 | 26 | PF00454 | 0.610 |
MOD_PK_1 | 190 | 196 | PF00069 | 0.548 |
MOD_PKA_2 | 57 | 63 | PF00069 | 0.207 |
MOD_PKA_2 | 80 | 86 | PF00069 | 0.420 |
MOD_PKB_1 | 18 | 26 | PF00069 | 0.673 |
MOD_Plk_4 | 190 | 196 | PF00069 | 0.690 |
MOD_ProDKin_1 | 144 | 150 | PF00069 | 0.480 |
TRG_ER_diArg_1 | 113 | 116 | PF00400 | 0.349 |
TRG_ER_diArg_1 | 18 | 20 | PF00400 | 0.540 |
TRG_NLS_MonoCore_2 | 16 | 21 | PF00514 | 0.537 |
TRG_NLS_MonoExtC_3 | 16 | 22 | PF00514 | 0.655 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P2U6 | Leptomonas seymouri | 44% | 100% |
A0A1X0P239 | Trypanosomatidae | 28% | 100% |
A0A3R7RIF0 | Trypanosoma rangeli | 28% | 100% |
A0A3S7X6R7 | Leishmania donovani | 84% | 99% |
A4HLI7 | Leishmania braziliensis | 77% | 100% |
A4I8Z7 | Leishmania infantum | 85% | 100% |
D0A4Z8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 30% | 100% |
Q4Q458 | Leishmania major | 83% | 100% |
V5BLV0 | Trypanosoma cruzi | 29% | 100% |